Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac troponin C (cTnC) is a calcium-binding protein that regulates cardiac muscle contraction. It is a subunit of the troponin complex, which controls the interaction between actin and myosin filaments. cTnC senses cytoplasmic calcium levels, triggering conformational changes that relieve the inhibition of actomyosin ATPase, enabling muscle contraction. Mutations in TNNC1, the gene encoding cTnC, are associated with cardiomyopathies. Cardiac troponins, including TnI and TnT, are used as biomarkers for myocardial injury.
Modulation of thin filament regulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac Troponin C (None).